Hoskin_1985_Biochem.Pharmacol_34_2069

Reference

Title : Inhibition of a soman- and diisopropyl phosphorofluoridate (DFP)-detoxifying enzyme by Mipafox - Hoskin_1985_Biochem.Pharmacol_34_2069
Author(s) : Hoskin FC
Ref : Biochemical Pharmacology , 34 :2069 , 1985
Abstract :

Mipafox, N,N'-diisopropylphosphordiamidofluoridate, has been found to be a reversible competitive inhibitor of a diisopropyl phosphorofluoridate hydrolyzing enzyme (DFPase) isolated from hog kidney and Escherichia coli. Heretofore, this DFPase was characterized by its more rapid hydrolysis of Soman (1,2,2-trimethylpropyl methylphosphonofluoridate), its stimulation by Mn2+, and its wide distribution. In sharp contrast, Mipafox did not inhibit the DFPase found only in cephalopod nerve, hepatopancreas, and saliva, and further characterized by its more rapid hydrolysis of DFP than of Soman, and its indifference to Mn2+. Neither of these two DFPases hydrolyzed Mipafox.

PubMedSearch : Hoskin_1985_Biochem.Pharmacol_34_2069
PubMedID: 4004925

Related information

Citations formats

Hoskin FC (1985)
Inhibition of a soman- and diisopropyl phosphorofluoridate (DFP)-detoxifying enzyme by Mipafox
Biochemical Pharmacology 34 :2069

Hoskin FC (1985)
Biochemical Pharmacology 34 :2069